| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 16 | 2023 | 449 | 4.320 |
Why?
|
| Adipose Tissue | 16 | 2023 | 327 | 4.280 |
Why?
|
| Gene Expression Regulation | 13 | 2023 | 481 | 2.670 |
Why?
|
| Polymorphism, Single Nucleotide | 29 | 2022 | 1079 | 2.560 |
Why?
|
| Obesity | 15 | 2023 | 1063 | 2.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 25 | 2022 | 1379 | 2.470 |
Why?
|
| African Americans | 18 | 2020 | 1373 | 2.010 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2022 | 836 | 1.900 |
Why?
|
| Subcutaneous Fat | 6 | 2017 | 42 | 1.840 |
Why?
|
| Chromosomes, Human, Pair 1 | 10 | 2013 | 35 | 1.840 |
Why?
|
| Glucose | 9 | 2020 | 163 | 1.730 |
Why?
|
| European Continental Ancestry Group | 20 | 2019 | 1131 | 1.650 |
Why?
|
| DNA Methylation | 3 | 2020 | 130 | 1.290 |
Why?
|
| Muscles | 3 | 2018 | 53 | 1.200 |
Why?
|
| Muscle, Skeletal | 8 | 2016 | 494 | 1.180 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 320 | 1.180 |
Why?
|
| Polymorphism, Genetic | 10 | 2010 | 196 | 1.160 |
Why?
|
| Quantitative Trait Loci | 6 | 2019 | 140 | 1.100 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 543 | 1.030 |
Why?
|
| Adult | 31 | 2020 | 8420 | 0.950 |
Why?
|
| Humans | 64 | 2023 | 29093 | 0.910 |
Why?
|
| Adipocytes | 3 | 2019 | 79 | 0.910 |
Why?
|
| Middle Aged | 31 | 2018 | 10829 | 0.850 |
Why?
|
| Insulin | 8 | 2018 | 346 | 0.840 |
Why?
|
| Thiazolidinediones | 2 | 2012 | 47 | 0.750 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 98 | 0.730 |
Why?
|
| Male | 37 | 2020 | 17807 | 0.720 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 4 | 0.700 |
Why?
|
| Female | 35 | 2020 | 18164 | 0.700 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 176 | 0.680 |
Why?
|
| Adiposity | 2 | 2018 | 191 | 0.670 |
Why?
|
| Transferrin | 1 | 2018 | 32 | 0.670 |
Why?
|
| African Continental Ancestry Group | 6 | 2015 | 350 | 0.640 |
Why?
|
| Young Adult | 11 | 2018 | 2402 | 0.620 |
Why?
|
| Endoplasmic Reticulum | 4 | 2012 | 24 | 0.610 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 83 | 0.610 |
Why?
|
| Triglycerides | 2 | 2017 | 214 | 0.600 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 165 | 0.590 |
Why?
|
| Phenotype | 9 | 2022 | 629 | 0.580 |
Why?
|
| Allelic Imbalance | 2 | 2013 | 6 | 0.560 |
Why?
|
| Computational Biology | 4 | 2020 | 86 | 0.550 |
Why?
|
| Gene Expression | 7 | 2022 | 332 | 0.550 |
Why?
|
| Prediabetic State | 3 | 2017 | 54 | 0.530 |
Why?
|
| Adolescent | 13 | 2018 | 3254 | 0.510 |
Why?
|
| Glucose Tolerance Test | 6 | 2017 | 125 | 0.510 |
Why?
|
| Genotype | 11 | 2019 | 735 | 0.500 |
Why?
|
| Body Mass Index | 9 | 2022 | 865 | 0.490 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 3 | 0.470 |
Why?
|
| Genetics, Population | 2 | 2005 | 30 | 0.460 |
Why?
|
| Phospholipids | 1 | 2013 | 26 | 0.460 |
Why?
|
| Blood Glucose | 3 | 2014 | 466 | 0.450 |
Why?
|
| Genetic Testing | 1 | 2013 | 90 | 0.440 |
Why?
|
| MicroRNAs | 1 | 2015 | 173 | 0.430 |
Why?
|
| Chromosome Mapping | 9 | 2016 | 190 | 0.430 |
Why?
|
| Genome, Human | 3 | 2009 | 129 | 0.420 |
Why?
|
| Case-Control Studies | 10 | 2018 | 859 | 0.420 |
Why?
|
| Mutation | 6 | 2008 | 466 | 0.410 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2011 | 2 | 0.410 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 106 | 0.380 |
Why?
|
| Oleic Acid | 1 | 2010 | 7 | 0.380 |
Why?
|
| Palmitates | 1 | 2010 | 4 | 0.380 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 80 | 0.370 |
Why?
|
| Osteocalcin | 1 | 2010 | 9 | 0.370 |
Why?
|
| Oxidative Stress | 1 | 2011 | 223 | 0.350 |
Why?
|
| Stress, Physiological | 2 | 2008 | 44 | 0.340 |
Why?
|
| RNA, Messenger | 7 | 2013 | 514 | 0.340 |
Why?
|
| Cell Line | 4 | 2018 | 449 | 0.340 |
Why?
|
| Membrane Proteins | 5 | 2017 | 256 | 0.340 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2008 | 2 | 0.330 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2018 | 17 | 0.330 |
Why?
|
| Down-Regulation | 3 | 2014 | 143 | 0.310 |
Why?
|
| Globins | 3 | 2002 | 3 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1013 | 0.300 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 17 | 0.290 |
Why?
|
| India | 11 | 2005 | 61 | 0.280 |
Why?
|
| Databases, Genetic | 1 | 2005 | 35 | 0.270 |
Why?
|
| Calsequestrin | 1 | 2004 | 2 | 0.260 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 73 | 0.260 |
Why?
|
| DNA Mutational Analysis | 3 | 2002 | 67 | 0.260 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 109 | 0.250 |
Why?
|
| Homeostasis | 3 | 2015 | 127 | 0.250 |
Why?
|
| Liver | 6 | 2017 | 464 | 0.240 |
Why?
|
| Animals | 10 | 2023 | 7297 | 0.240 |
Why?
|
| PPAR gamma | 3 | 2014 | 45 | 0.240 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2013 | 47 | 0.230 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 35 | 0.220 |
Why?
|
| Aged | 13 | 2018 | 9487 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 118 | 0.220 |
Why?
|
| Linkage Disequilibrium | 9 | 2009 | 192 | 0.220 |
Why?
|
| Sequence Deletion | 2 | 2009 | 36 | 0.220 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2013 | 21 | 0.220 |
Why?
|
| beta-Thalassemia | 5 | 2002 | 6 | 0.210 |
Why?
|
| Gene Frequency | 7 | 2018 | 225 | 0.200 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 9 | 0.200 |
Why?
|
| Fetal Hemoglobin | 1 | 2001 | 4 | 0.200 |
Why?
|
| Genomics | 2 | 2011 | 82 | 0.190 |
Why?
|
| Waist-Hip Ratio | 4 | 2013 | 33 | 0.180 |
Why?
|
| Exons | 3 | 2010 | 49 | 0.180 |
Why?
|
| Biopsy | 2 | 2023 | 241 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 65 | 0.170 |
Why?
|
| TCF Transcription Factors | 2 | 2010 | 8 | 0.170 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.170 |
Why?
|
| Ferritins | 1 | 2018 | 46 | 0.170 |
Why?
|
| Blotting, Western | 1 | 2019 | 281 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1356 | 0.160 |
Why?
|
| Macrophages | 2 | 2022 | 188 | 0.160 |
Why?
|
| Activating Transcription Factor 6 | 2 | 2008 | 3 | 0.160 |
Why?
|
| Inflammation | 2 | 2012 | 507 | 0.160 |
Why?
|
| Iron | 1 | 2018 | 113 | 0.160 |
Why?
|
| Methylamines | 1 | 2017 | 2 | 0.160 |
Why?
|
| Oxygenases | 1 | 2017 | 3 | 0.160 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 9 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2017 | 19 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2018 | 1687 | 0.150 |
Why?
|
| Fatty Acids | 2 | 2022 | 92 | 0.140 |
Why?
|
| Europe | 3 | 2004 | 77 | 0.140 |
Why?
|
| Bipolar Disorder | 2 | 2005 | 15 | 0.140 |
Why?
|
| Schizophrenia | 2 | 2005 | 38 | 0.130 |
Why?
|
| Haplotypes | 5 | 2006 | 220 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 13 | 0.130 |
Why?
|
| Zebrafish | 1 | 2014 | 24 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 212 | 0.130 |
Why?
|
| G-Quadruplexes | 2 | 2012 | 8 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2014 | 57 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2008 | 139 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2006 | 23 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2013 | 131 | 0.120 |
Why?
|
| Genetic Association Studies | 2 | 2013 | 148 | 0.120 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2013 | 1 | 0.120 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hep G2 Cells | 2 | 2010 | 23 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 18 | 0.120 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 25 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2014 | 799 | 0.120 |
Why?
|
| Luciferases | 1 | 2013 | 27 | 0.120 |
Why?
|
| Ligands | 1 | 2012 | 81 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2012 | 29 | 0.110 |
Why?
|
| DNA | 3 | 2009 | 204 | 0.110 |
Why?
|
| Metabolism | 1 | 2011 | 7 | 0.100 |
Why?
|
| Adiponectin | 1 | 2012 | 103 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 71 | 0.100 |
Why?
|
| Genetic Variation | 6 | 2010 | 251 | 0.100 |
Why?
|
| Arkansas | 2 | 2008 | 2 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 248 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 195 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 136 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 142 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 172 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 141 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2011 | 183 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2009 | 172 | 0.090 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2008 | 5 | 0.090 |
Why?
|
| Risk Factors | 4 | 2022 | 3531 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2010 | 80 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2010 | 28 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 51 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 72 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2010 | 53 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2017 | 425 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 20 | 0.090 |
Why?
|
| Body Composition | 1 | 2011 | 365 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2014 | 693 | 0.080 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 3 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2008 | 3 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 12 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2008 | 8 | 0.080 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 25 | 0.080 |
Why?
|
| Family Health | 3 | 2008 | 78 | 0.080 |
Why?
|
| Pedigree | 3 | 2008 | 133 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 28 | 0.080 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2008 | 44 | 0.080 |
Why?
|
| Lipids | 2 | 2022 | 209 | 0.080 |
Why?
|
| Mice | 4 | 2017 | 2368 | 0.080 |
Why?
|
| Hemoglobin E | 2 | 1997 | 2 | 0.080 |
Why?
|
| Pyruvate Kinase | 2 | 2009 | 2 | 0.080 |
Why?
|
| International Cooperation | 1 | 2007 | 25 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 6 | 0.070 |
Why?
|
| Guanine | 1 | 2006 | 14 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 17 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2005 | 4 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2005 | 1 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2006 | 82 | 0.070 |
Why?
|
| Homocysteine | 1 | 2005 | 15 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2005 | 34 | 0.070 |
Why?
|
| Prognosis | 1 | 2010 | 1362 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 33 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 93 | 0.070 |
Why?
|
| Lipase | 2 | 2017 | 28 | 0.070 |
Why?
|
| Introns | 1 | 2004 | 39 | 0.060 |
Why?
|
| Time Factors | 1 | 2010 | 2001 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 129 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2004 | 122 | 0.060 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2003 | 2 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 9 | 0.060 |
Why?
|
| Peptides | 1 | 2004 | 118 | 0.060 |
Why?
|
| Primates | 1 | 2023 | 100 | 0.060 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2002 | 1 | 0.060 |
Why?
|
| Zinc Compounds | 1 | 2002 | 4 | 0.060 |
Why?
|
| Chlorides | 1 | 2002 | 15 | 0.060 |
Why?
|
| Reference Values | 3 | 2009 | 224 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 52 | 0.050 |
Why?
|
| Locus Control Region | 1 | 2002 | 1 | 0.050 |
Why?
|
| Alleles | 3 | 2012 | 251 | 0.050 |
Why?
|
| Collagen | 1 | 2022 | 217 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2022 | 179 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2012 | 77 | 0.050 |
Why?
|
| Hemoglobinopathies | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cytokines | 1 | 2022 | 243 | 0.050 |
Why?
|
| Social Conditions | 1 | 2001 | 2 | 0.050 |
Why?
|
| Malaria | 1 | 2001 | 10 | 0.050 |
Why?
|
| Ethnic Groups | 2 | 2009 | 440 | 0.050 |
Why?
|
| Geography | 1 | 2001 | 34 | 0.050 |
Why?
|
| Politics | 1 | 2001 | 20 | 0.050 |
Why?
|
| Emigration and Immigration | 1 | 2001 | 32 | 0.050 |
Why?
|
| Commerce | 1 | 2001 | 37 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2001 | 64 | 0.050 |
Why?
|
| Lod Score | 2 | 2011 | 71 | 0.050 |
Why?
|
| Indians, North American | 2 | 2013 | 108 | 0.050 |
Why?
|
| ROC Curve | 1 | 2018 | 149 | 0.040 |
Why?
|
| Body Constitution | 1 | 2018 | 26 | 0.040 |
Why?
|
| Visual Fields | 1 | 2018 | 25 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2010 | 454 | 0.040 |
Why?
|
| Utah | 2 | 2008 | 15 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 2 | 2009 | 46 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2018 | 66 | 0.040 |
Why?
|
| Deuterium | 1 | 2017 | 9 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 10 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 80 | 0.040 |
Why?
|
| Metabolomics | 1 | 2017 | 45 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2017 | 108 | 0.040 |
Why?
|
| Research Design | 1 | 2018 | 286 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2014 | 8 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 711 | 0.030 |
Why?
|
| Azacitidine | 1 | 2014 | 28 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 103 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 213 | 0.030 |
Why?
|
| Cell Movement | 1 | 2014 | 161 | 0.030 |
Why?
|
| Cell-Matrix Junctions | 1 | 2013 | 1 | 0.030 |
Why?
|
| alpha Catenin | 1 | 2013 | 1 | 0.030 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 3 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2013 | 9 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 32 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 104 | 0.030 |
Why?
|
| Tunicamycin | 1 | 2012 | 6 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2012 | 7 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 100 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2012 | 11 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 53 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2012 | 5 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 36 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2011 | 53 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2012 | 225 | 0.030 |
Why?
|
| RNA | 1 | 2012 | 88 | 0.030 |
Why?
|
| Base Sequence | 1 | 2012 | 240 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 350 | 0.030 |
Why?
|
| Family | 1 | 2011 | 105 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 720 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1604 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 56 | 0.020 |
Why?
|
| Homozygote | 2 | 2002 | 57 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 680 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 292 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2009 | 21 | 0.020 |
Why?
|
| Pancreas | 1 | 2010 | 79 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2008 | 89 | 0.020 |
Why?
|
| Apolipoprotein A-II | 1 | 2008 | 6 | 0.020 |
Why?
|
| Retinoid X Receptor gamma | 1 | 2008 | 2 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 54 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 45 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2008 | 92 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2008 | 149 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 67 | 0.020 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2007 | 110 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2006 | 6 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2006 | 9 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 18 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 21 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2006 | 30 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2002 | 1167 | 0.020 |
Why?
|
| Gene Components | 1 | 2005 | 3 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 631 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2005 | 5 | 0.020 |
Why?
|
| Logistic Models | 1 | 2008 | 727 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 87 | 0.020 |
Why?
|
| Schizophrenia, Catatonic | 1 | 2005 | 2 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2005 | 17 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2005 | 128 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2005 | 48 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 3717 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 1108 | 0.020 |
Why?
|
| Cysteine | 1 | 2005 | 131 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2005 | 159 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2003 | 6 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 5 | 0.010 |
Why?
|
| Child | 2 | 2002 | 2219 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 1305 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 100 | 0.010 |
Why?
|
| Micronucleus Tests | 1 | 2002 | 3 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 2002 | 9 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2002 | 14 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 13 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 64 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 641 | 0.010 |
Why?
|
| United States | 1 | 2008 | 3630 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 969 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 7 | 0.010 |
Why?
|
| Point Mutation | 1 | 1997 | 23 | 0.010 |
Why?
|
| Heterozygote | 1 | 1997 | 52 | 0.010 |
Why?
|